| 49281-860-10 |
49281-860 |
VACCINE |
IPOL |
POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) |
INJECTION, SUSPENSION |
INTRAMUSCULAR |
19901221 |
N/A |
BLA |
BLA103930 |
Sanofi Pasteur Inc. |
POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) |
40 [D'ag'U]/.5mL; 8 [D'ag'U]/.5mL; 32 [D'ag'U]/.5mL |
1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-860-10) / 5 mL in 1 VIAL, MULTI-DOSE (49281-860-78) |
| 50090-1693-9 |
50090-1693 |
VACCINE |
IPOL |
POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) |
INJECTION, SUSPENSION |
INTRAMUSCULAR |
19901221 |
N/A |
BLA |
BLA103930 |
A-S Medication Solutions |
POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED); POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) |
40 [D'ag'U]/.5mL; 8 [D'ag'U]/.5mL; 32 [D'ag'U]/.5mL |
1 VIAL, MULTI-DOSE in 1 PACKAGE (50090-1693-9) / 5 mL in 1 VIAL, MULTI-DOSE (50090-1693-0) |